Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 2:46 pm Purchase | 2024-09-30 | 13G | 10x Genomics, Inc. TXG | Nikko Asset Management Americas Inc. | 6,373,212 5.980% | 6,373,212 (New Position) | Filing History |
| 2024-11-05 06:07 am Purchase | 2024-09-30 | 13G | 10x Genomics, Inc. TXG | Sumitomo Mitsui Trust Holdings Inc. | 6,373,212 5.980% | 6,373,212 (New Position) | Filing History |
| 2024-10-04 2:14 pm Purchase | 2024-09-30 | 13G | 10x Genomics, Inc. TXG | VANGUARD GROUP INC | 10,972,930 10.300% | 1,961,598 (+21.77%) | Filing History |
| 2024-08-12 11:16 am Purchase | 2024-07-31 | 13G | 10x Genomics, Inc. TXG | ARK Investment Management LLC | 11,357,011 10.750% | 11,357,011 (New Position) | Filing History |
| 2024-06-07 09:55 am Sale | 2024-05-31 | 13G | 10x Genomics, Inc. TXG | BAILLIE GIFFORD & CO | 2,777,115 2.630% | -5,142,861 (-64.94%) | Filing History |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | 10x Genomics, Inc. TXG | VANGUARD GROUP INC | 9,011,332 8.650% | 591,321 (+7.02%) | Filing History |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 17,731,269 16.252% | 4,683,939 (+35.90%) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 5,705,051 5.500% | 385,872 (+7.25%) | Filing History |
| 2024-01-29 11:43 am Sale | 2023-12-29 | 13G | 10x Genomics, Inc. TXG | BAILLIE GIFFORD & CO | 7,919,976 7.600% | -682,259 (-7.93%) | Filing History |
| 2023-12-08 4:37 pm Sale | 2023-11-30 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 3,630,398 3.500% | -1,509,063 (-29.36%) | Filing History |
| 2023-07-10 4:38 pm Sale | 2023-06-30 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 5,139,461 5.200% | -4,755,518 (-48.06%) | Filing History |
| 2023-07-10 10:20 am Purchase | 2023-07-07 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 13,047,330 12.658% | 4,154,232 (+46.71%) | Filing History |
| 2023-02-14 4:05 pm Unchanged | 2022-12-31 | 13G | 10x Genomics, Inc. TXG | Venrock Associates VI L.P. | 4,828,247 4.900% | 0 (Unchanged) | Filing History |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | 10x Genomics, Inc. TXG | VANGUARD GROUP INC | 8,420,011 8.810% | 865,969 (+11.46%) | Filing History |
| 2023-02-09 08:14 am Sale | 2023-02-09 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 8,893,098 8.780% | -4,385,709 (-33.03%) | Filing History |
| 2023-02-08 11:17 am Sale | 2022-12-30 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 9,894,979 10.400% | -446,774 (-4.32%) | Filing History |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 5,319,179 5.600% | 327,892 (+6.57%) | Filing History |
| 2023-01-18 06:24 am Purchase | 2022-12-30 | 13G | 10x Genomics, Inc. TXG | BAILLIE GIFFORD & CO | 8,602,235 9.000% | 1,723,858 (+25.06%) | Filing History |
| 2022-09-12 4:29 pm Purchase | 2022-08-31 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 10,341,753 10.900% | 5,732,995 (+124.39%) | Filing History |
| 2022-08-09 4:02 pm Sale | 2022-07-31 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 4,991,287 5.300% | -5,236,386 (-51.20%) | Filing History |